Analyst Corner: ‘Hold’ on Dr Lal Pathlabs with DCF-based target price of Rs 3,405
However, considering recent rally in the stock price which has made valuations fair, we downgrade it to HOLD from Add.
However, considering recent rally in the stock price which has made valuations fair, we downgrade it to HOLD from Add.